<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854019/" ref="ordinalpos=3658&amp;ncbi_uid=5605112&amp;link_uid=PMC3854019" image-link="/pmc/articles/PMC3854019/figure/pharmaceuticals-06-01429-f001/" class="imagepopup">Figure 1.  From: Hedgehog <span class="highlight" style="background-color:">Pathway</span> Blockade Inhibits Melanoma Cell Growth in Vitro and in Vivo. </a></div><br /><div class="p4l_captionBody">Hedgehog pathway members are upregulated in a subset of melanoma cell lines as measured via affymetrix microarray analysis. SMO, GLI2, PTCH1, and WNT5a are upregulated, while negative regulators of hedgehog signaling such as protein kinase A (PRKA) and dual specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2) are downregulated as compared to melanocytes.</div></div>